US2012077742A1PendingUtilityA1
Expression System Of NELL Peptide
Est. expiryFeb 9, 2024(expired)· nominal 20-yr term from priority
C07K 14/51A61P 19/04A61P 19/08A61P 19/00C12N 15/63C12N 1/20C07K 14/705C12N 15/11
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Recombinant NELL peptides and methods of preparing the same are disclosed.
Claims
exact text as granted — not AI-modified1 . A composition for inducing bone or cartilage formation comprising: an effective amount of a recombinant Nel-like molecule-1 (NELL-1) peptide comprising an amino acid sequence of SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:12, and SEQ ID NO:14, and a carrier, wherein the carrier comprises a physiologically acceptable carrier that forms an implant or scaffold that provides for bone or cartilage formation.
2 . The composition of claim 1 , wherein the NELL-1 peptide further comprises a NELL1 or NELL2 secretory peptide.
3 . The composition of claim 1 , wherein the carrier is a scaffold.
4 . The composition of claim 1 , which is in a formulation for injection into a fracture site or implantation.
5 . The composition of claim 1 , further comprising another agent.
6 . The composition of claim 5 , wherein the another agent is a selected from the group consisting of bone morphogenetic protein (BMP), a fibroblast growth factor (FGF), a transforming growth factor-β (TGF-β), an insulin-like growth factor (IGF), a vascular endothelial growth factor (VEGF), a platelet-derived growth factor (PDGF), a parathyroid hormone (PTH), a PTH-regulated protein) PTHrp), growth/differentiation factor 5 (GDF5); and LIM mineralization proteins (LMPs).Join the waitlist — get patent alerts
Track US2012077742A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.